Comera life sciences announces up to $15 million purchase agreement with arena business solutions

Woburn, mass., aug. 31, 2022 (globe newswire) -- comera life sciences holdings, inc. (nasdaq: cmra) (“company” or “comera”), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, today announced entry into a purchase agreement with arena business solutions global spc ii, ltd. (“arena”) for up to $15 million of the company's common stock, with an option to increase by an additional $15 million to $30 million.
CMRA Ratings Summary
CMRA Quant Ranking